Evidence map›Paper›PMID 36969941›Full record

ArticleInfection and drug resistance2023

A Case of Severe

Jun Hirai, Nobuaki Mori, Hideo Kato, Nobuhiro Asai, Mao Hagihara, Hiroshige Mikamo

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jun HiraiDepartment of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute, Aichi, Japan.ORCID 0000-0001-9184-7175
Nobuaki MoriDepartment of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute, Aichi, Japan.ORCID 0000-0002-1433-0276
Hideo KatoDepartment of Pharmacy, Mie University Hospital, Mie, Japan.
Nobuhiro AsaiDepartment of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute, Aichi, Japan.
Mao HagiharaDepartment of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Nagakute, Aichi, Japan.
Hiroshige MikamoDepartment of Clinical Infectious Diseases, Aichi Medical University Hospital, Nagakute, Aichi, Japan.
Aichi Medical University Hospital · JPAichi Medical University · JPMie University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Currently, atovaquone is not recommended for treating severe

Indexed as

atovaquonecorticosteroidPneumocystis pneumoniaseveretrimethoprim-sulfamethoxazole

Identifiers

PMID36969941
PMCPMC10032339
OpenAlexW4327717377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.